Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors (Q42544723)
Jump to navigation
Jump to search
scientific article published on January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors |
scientific article published on January 1998 |
Statements
1 reference
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors (English)
1 reference
Tranchand B
1 reference
Catimel G
1 reference
Lucas C
1 reference
Sarkany M
1 reference
Bastian G
1 reference
Evene E
1 reference
Guastalla JP
1 reference
Négrier S
1 reference
Rebattu P
1 reference
Dumortier A
1 reference
Foy M
1 reference
Grossin F
1 reference
Mazier B
1 reference
Froudarakis M
1 reference
Barbet N
1 reference
Clavel M
1 reference
Ardiet C
1 reference
1 January 1998
1 reference
1 reference
41
1 reference
4
1 reference
281-291
1 reference
Identifiers
1 reference
1 reference